Selling And Administration Expenses 更改
AbbVie USD 3.61B 273M 2023-12
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Genmab DKK 839M 9M 2023-09
Geron USD 21.4M 3.05M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Xencor USD 15.48M 2.98M 2023-12



MacroGenics 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Apr 2024.